Is Osteogenesis Imperfecta Associated with Cardiovascular Abnormalities? A Systematic Review of the Literature.
Sara J E VerdonkSilvia StoroniDimitra MichaJoost G van den AardwegPaolo VersacciLuca CelliRalph de VriesLidiia ZhytnikOtto KampMarianna BugianiElisabeth M W EekhoffPublished in: Calcified tissue international (2024)
Osteogenesis imperfecta (OI) is a rare genetic disorder caused by abnormal collagen type I production. While OI is primarily characterized by bone fragility and deformities, patients also have extraskeletal manifestations, including an increased risk of cardiovascular disease. This review provides a comprehensive overview of the literature on cardiovascular diseases in OI patients in order to raise awareness of this understudied clinical aspect of OI and support clinical guidelines. In accordance with the PRISMA guidelines, a systematic literature search in PubMed, Embase, Web of Science and Scopus was conducted that included articles from the inception of these databases to April 2023. Valvular disease, heart failure, atrial fibrillation, and hypertension appear to be more prevalent in OI than in control individuals. Moreover, a larger aortic root was observed in OI compared to controls. Various cardiovascular diseases appear to be more prevalent in OI than in controls. These cardiovascular abnormalities are observed in all types of OI and at all ages, including young children. As there are insufficient longitudinal studies, it is unknown whether these abnormalities are progressive in nature in OI patients. Based on these findings, we would recommend referring individuals with OI to a cardiologist with a low-threshold.
Keyphrases
- cardiovascular disease
- end stage renal disease
- heart failure
- atrial fibrillation
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- systematic review
- blood pressure
- type diabetes
- multiple sclerosis
- coronary artery disease
- randomized controlled trial
- coronary artery
- pulmonary hypertension
- machine learning
- body composition
- venous thromboembolism
- cardiovascular events
- percutaneous coronary intervention
- big data
- soft tissue
- pulmonary arterial hypertension
- case control